Trial Profile
Irinotecan combined with infusional 5-FU [fluorouracil]/folinic acid or capecitabine and the role of celecoxib in patients with metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Oct 2012
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Capecitabine; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions; Registrational; Therapeutic Use
- 01 May 2008 Results published in the Annals of Oncology.
- 30 Sep 2005 New trial record.